South Korea
· Delayed Price · Currency is KRW Amicogen Statistics
Total Valuation
Amicogen has a market cap or net worth of KRW 197.89 billion. The enterprise value is 310.51 billion.
| Market Cap | 197.89B |
| Enterprise Value | 310.51B |
Important Dates
The next estimated earnings date is Thursday, August 14, 2025.
| Earnings Date | Aug 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Amicogen has 54.82 million shares outstanding. The number of shares has increased by 25.76% in one year.
| Current Share Class | 54.82M |
| Shares Outstanding | 54.82M |
| Shares Change (YoY) | +25.76% |
| Shares Change (QoQ) | -0.37% |
| Owned by Insiders (%) | 4.92% |
| Owned by Institutions (%) | 6.25% |
| Float | 52.12M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.32 |
| PB Ratio | 1.56 |
| P/TBV Ratio | 1.70 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 30.10 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 79.97, with an EV/FCF ratio of -13.61.
| EV / Earnings | -5.86 |
| EV / Sales | 2.07 |
| EV / EBITDA | 79.97 |
| EV / EBIT | n/a |
| EV / FCF | -13.61 |
Financial Position
The company has a current ratio of 0.89, with a Debt / Equity ratio of 0.94.
| Current Ratio | 0.89 |
| Quick Ratio | 0.65 |
| Debt / Equity | 0.94 |
| Debt / EBITDA | 30.93 |
| Debt / FCF | -5.26 |
| Interest Coverage | -0.87 |
Financial Efficiency
Return on equity (ROE) is -29.66% and return on invested capital (ROIC) is -1.74%.
| Return on Equity (ROE) | -29.66% |
| Return on Assets (ROA) | -1.46% |
| Return on Invested Capital (ROIC) | -1.74% |
| Return on Capital Employed (ROCE) | -4.56% |
| Revenue Per Employee | 667.77M |
| Profits Per Employee | -235.38M |
| Employee Count | 225 |
| Asset Turnover | 0.39 |
| Inventory Turnover | 3.53 |
Taxes
In the past 12 months, Amicogen has paid 9.83 million in taxes.
| Income Tax | 9.83M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -52.25% in the last 52 weeks. The beta is 0.79, so Amicogen's price volatility has been lower than the market average.
| Beta (5Y) | 0.79 |
| 52-Week Price Change | -52.25% |
| 50-Day Moving Average | 3,537.10 |
| 200-Day Moving Average | 3,982.48 |
| Relative Strength Index (RSI) | 45.80 |
| Average Volume (20 Days) | 1,317,916 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Amicogen had revenue of KRW 150.25 billion and -52.96 billion in losses. Loss per share was -963.57.
| Revenue | 150.25B |
| Gross Profit | 41.46B |
| Operating Income | -8.93B |
| Pretax Income | -51.27B |
| Net Income | -52.96B |
| EBITDA | 3.88B |
| EBIT | -8.93B |
| Loss Per Share | -963.57 |
Balance Sheet
The company has 17.72 billion in cash and 120.09 billion in debt, giving a net cash position of -102.37 billion or -1,867.49 per share.
| Cash & Cash Equivalents | 17.72B |
| Total Debt | 120.09B |
| Net Cash | -102.37B |
| Net Cash Per Share | -1,867.49 |
| Equity (Book Value) | 127.15B |
| Book Value Per Share | 2,132.49 |
| Working Capital | -8.68B |
Cash Flow
In the last 12 months, operating cash flow was 6.57 billion and capital expenditures -29.39 billion, giving a free cash flow of -22.82 billion.
| Operating Cash Flow | 6.57B |
| Capital Expenditures | -29.39B |
| Free Cash Flow | -22.82B |
| FCF Per Share | -416.33 |
Margins
Gross margin is 27.59%, with operating and profit margins of -5.95% and -35.25%.
| Gross Margin | 27.59% |
| Operating Margin | -5.95% |
| Pretax Margin | -34.13% |
| Profit Margin | -35.25% |
| EBITDA Margin | 2.58% |
| EBIT Margin | -5.95% |
| FCF Margin | n/a |
Dividends & Yields
Amicogen does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -25.76% |
| Shareholder Yield | -25.76% |
| Earnings Yield | -26.76% |
| FCF Yield | -11.53% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on December 13, 2023. It was a forward split with a ratio of 2.
| Last Split Date | Dec 13, 2023 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
Amicogen has an Altman Z-Score of 1.31 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.31 |
| Piotroski F-Score | 5 |